Prostate cancer is the second most common cancer diagnosed in men in Australia and the third most common cause of cancer death. Prostate cancer develops when abnormal cells in the prostate gland grow in an uncontrolled way, forming a malignant tumour.
My name is Mikhail Dias, I recently completed an honours year at Monash University where I researched an in silico approach to studying synthetic lethality in cancer to identify novel gene targets.
I am become passionate about cancer biology during my undergraduate studies at RMIT university, where I learned about cancer genomics and how genetic alterations can lead to devastating consequences. I pursued a pathway into research by undertaking an honours year project at Monash University. During my honour’s year, I developed sought after computational skills and experience which I will continue to use throughout my research career.
Read more >My interest in cancer research began while studying my Bachelor of Science in Biomedical Science at the University of Auckland. I was intrigued by the different fields of cancer research and specialised my degree to a research area in Cell Biology and Cancer Therapeutics. I then continued my research at the University of Melbourne and Peter MacCallum Cancer Centre, completing my Master of Biomedical Science in Prof Grant McArthur’s Molecular Oncology lab.
Under the supervision of Dr Lorey Smith and Dr Karen Sheppard, my project investigated metabolic reprogramming that occurs in response to BRAF/MEK and CDK4/6 targeted therapies in melanoma.
Read more >
